InsidersTradesSigma
Browse the complete record of transactions filed by Gray Peter, Director. Director active across 1 companies, notably Jazz Pharmaceuticals plc. Aggregated, 4 disclosures have been published. Total volume traded: €354k. The latest transaction was filed on 6 August 2021 — Cession. Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations
Peter Gray is a Board Member at Jazz Pharmaceuticals plc. He brings his expertise in governance and corporate strategy, actively participating in discussions and decisions within the board.